• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过多细胞 3D 生物打印策略在体外构建具有仿生小叶结构的肝类器官。

In vitro construction of liver organoids with biomimetic lobule structure by a multicellular 3D bioprinting strategy.

机构信息

State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, China.

University of Chinese Academy of Sciences, Beijing, China.

出版信息

Cell Prolif. 2023 May;56(5):e13465. doi: 10.1111/cpr.13465. Epub 2023 May 17.

DOI:10.1111/cpr.13465
PMID:37199010
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10212698/
Abstract

Liver disease is one of the serious threats to human life and health. Three-dimensional (3D) liver models, which simulate the structure and function of natural liver tissue in vitro, have become a common demand in medical, scientific and pharmaceutical fields nowadays. However, the complex cellular composition and multi-scale spatial arrangement of liver tissue make it extremely challenging to construct liver models in vitro. According to HepaRG preference and printing strategy, the formulation of bioink system with opposite charge is optimized. The sodium alginate-based bioink 1 and dipeptide-based bioink 2 are used to ensure structural integrity and provide flexible designability, respectively. The HepaRG/HUVECs/LX-2-laden liver organoids with biomimetic lobule structure are fabricated by a multicellular 3D droplet-based bioprinting strategy, to mimic the cell heterogeneity, spatial structure and extracellular matrix (ECM) features. The liver organoids can maintain structural integrity and multicellular distribution within the printed lobule-like structure after 7 days of culture. Compared with the 2D monolayer culture, the constructed 3D organoids show high cell viability, ALB secretion and urea synthesis levels. This study provides a droplet-based and layer-by-layer 3D bioprinting strategy for in vitro construction of liver organoids with biomimetic lobule structure, giving meaningful insights in the fields of new drugs, disease modelling, and tissue regeneration.

摘要

肝脏疾病是人类生命和健康的严重威胁之一。目前,在医学、科学和制药领域,模拟天然肝组织结构和功能的三维(3D)肝脏模型已成为一种常见需求。然而,肝脏组织复杂的细胞组成和多尺度空间排列使得在体外构建肝脏模型极具挑战性。根据 HepaRG 的偏好和打印策略,优化了带有相反电荷的生物墨水系统配方。基于海藻酸钠的生物墨水 1 和二肽基生物墨水 2 分别用于确保结构完整性和提供灵活的可设计性。通过基于多细胞 3D 液滴的生物打印策略构建具有仿生小叶结构的 HepaRG/HUVECs/LX-2 负载的肝类器官,以模拟细胞异质性、空间结构和细胞外基质(ECM)特征。在培养 7 天后,打印的小叶状结构内的肝类器官保持结构完整性和多细胞分布。与 2D 单层培养相比,构建的 3D 类器官显示出更高的细胞活力、ALB 分泌和尿素合成水平。本研究提供了一种基于液滴和逐层 3D 生物打印策略,用于体外构建具有仿生小叶结构的肝类器官,为新药研发、疾病建模和组织再生等领域提供了有意义的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/906e/10212698/b38ad620486e/CPR-56-e13465-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/906e/10212698/aa2489b9b986/CPR-56-e13465-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/906e/10212698/c6d4bab7044c/CPR-56-e13465-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/906e/10212698/fad8397f6426/CPR-56-e13465-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/906e/10212698/b38ad620486e/CPR-56-e13465-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/906e/10212698/aa2489b9b986/CPR-56-e13465-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/906e/10212698/c6d4bab7044c/CPR-56-e13465-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/906e/10212698/fad8397f6426/CPR-56-e13465-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/906e/10212698/b38ad620486e/CPR-56-e13465-g005.jpg

相似文献

1
In vitro construction of liver organoids with biomimetic lobule structure by a multicellular 3D bioprinting strategy.通过多细胞 3D 生物打印策略在体外构建具有仿生小叶结构的肝类器官。
Cell Prolif. 2023 May;56(5):e13465. doi: 10.1111/cpr.13465. Epub 2023 May 17.
2
Hyaluronic acid methacrylate/pancreatic extracellular matrix as a potential 3D printing bioink for constructing islet organoids.甲基丙烯酰化透明质酸/胰腺细胞外基质作为一种潜在的 3D 打印生物墨水用于构建胰岛类器官。
Acta Biomater. 2023 Jul 15;165:86-101. doi: 10.1016/j.actbio.2022.06.036. Epub 2022 Jul 6.
3
Small Joint Organoids 3D Bioprinting: Construction Strategy and Application.小关节类器官 3D 生物打印:构建策略与应用。
Small. 2024 Feb;20(8):e2302506. doi: 10.1002/smll.202302506. Epub 2023 Oct 9.
4
ECM Based Bioink for Tissue Mimetic 3D Bioprinting.基于细胞外基质的生物墨水用于组织模拟的 3D 生物打印。
Adv Exp Med Biol. 2018;1064:335-353. doi: 10.1007/978-981-13-0445-3_20.
5
Bioprinting of 3D Tissue Models Using Decellularized Extracellular Matrix Bioink.使用脱细胞细胞外基质生物墨水进行3D组织模型的生物打印。
Methods Mol Biol. 2017;1612:381-390. doi: 10.1007/978-1-4939-7021-6_27.
6
Expanding Embedded 3D Bioprinting Capability for Engineering Complex Organs with Freeform Vascular Networks.扩展嵌入式 3D 生物打印能力,用于构建具有自由形态血管网络的复杂器官。
Adv Mater. 2023 Jun;35(22):e2205082. doi: 10.1002/adma.202205082. Epub 2023 Apr 8.
7
Generation of a 3D Liver Model Comprising Human Extracellular Matrix in an Alginate/Gelatin-Based Bioink by Extrusion Bioprinting for Infection and Transduction Studies.通过挤出式生物打印在藻酸盐/明胶基生物墨水中生成包含人细胞外基质的 3D 肝脏模型,用于感染和转导研究。
Int J Mol Sci. 2018 Oct 12;19(10):3129. doi: 10.3390/ijms19103129.
8
Three-Dimensional Bioprinting of Organoids: Past, Present, and Prospective.类器官的三维生物打印:过去、现在和未来。
Tissue Eng Part A. 2024 Jun;30(11-12):314-321. doi: 10.1089/ten.TEA.2023.0209. Epub 2024 Feb 2.
9
3D culture of HepaRG cells in GelMa and its application to bioprinting of a multicellular hepatic model.HepaRG 细胞在 GelMa 中的 3D 培养及其在多细胞肝模型生物打印中的应用。
Biomaterials. 2021 Feb;269:120611. doi: 10.1016/j.biomaterials.2020.120611. Epub 2020 Dec 16.
10
Post-decellularized printing of cartilage extracellular matrix: distinction between biomaterial ink and bioink.软骨细胞外基质的脱细胞后打印:生物材料墨水与生物墨水的区别
Biomater Sci. 2023 Mar 28;11(7):2317-2329. doi: 10.1039/d2bm02111k.

引用本文的文献

1
Immune organoids: emerging platforms for modeling and analyzing human adaptive immunity.免疫类器官:用于模拟和分析人类适应性免疫的新兴平台。
Front Immunol. 2025 Aug 6;16:1632117. doi: 10.3389/fimmu.2025.1632117. eCollection 2025.
2
Innovative strategies for bone organoid: Synergistic application and exploration of advanced technologies.骨类器官的创新策略:先进技术的协同应用与探索
J Orthop Translat. 2025 Aug 14;54:180-198. doi: 10.1016/j.jot.2025.07.010. eCollection 2025 Sep.
3
The application of liver cancer organoids in tumour precision medicine: A comprehensive review.

本文引用的文献

1
Thyroid-on-a-Chip: An Organoid Platform for In Vitro Assessment of Endocrine Disruption.甲状腺芯片:用于内分泌干扰体外评估的类器官平台。
Adv Healthc Mater. 2023 Mar;12(8):e2201555. doi: 10.1002/adhm.202201555. Epub 2023 Jan 10.
2
Advances in 3D bioprinting technology for liver regeneration.用于肝脏再生的3D生物打印技术进展。
Hepatobiliary Surg Nutr. 2022 Dec;11(6):917-919. doi: 10.21037/hbsn-22-531.
3
Current trends and research topics regarding liver 3D bioprinting: A bibliometric analysis research.关于肝脏3D生物打印的当前趋势和研究主题:一项文献计量分析研究。
肝癌类器官在肿瘤精准医学中的应用:一项综述
ILIVER. 2025 Jul 5;4(3):100179. doi: 10.1016/j.iliver.2025.100179. eCollection 2025 Sep.
4
Organoids in Haematologic Research: Advances and Future Directions.血液学研究中的类器官:进展与未来方向
Cell Prolif. 2025 Jun;58(6):e13806. doi: 10.1111/cpr.13806. Epub 2025 Jan 26.
5
Advances, challenges and future applications of liver organoids in experimental regenerative medicine.肝脏类器官在实验性再生医学中的进展、挑战及未来应用
Front Med (Lausanne). 2025 Jan 24;11:1521851. doi: 10.3389/fmed.2024.1521851. eCollection 2024.
6
The Prospect of Hepatic Decellularized Extracellular Matrix as a Bioink for Liver 3D Bioprinting.肝去细胞化细胞外基质作为肝脏 3D 生物打印生物墨水的前景。
Biomolecules. 2024 Aug 16;14(8):1019. doi: 10.3390/biom14081019.
7
Advances in 3D bioprinting for regenerative medicine applications.用于再生医学应用的3D生物打印技术进展。
Regen Biomater. 2024 Mar 26;11:rbae033. doi: 10.1093/rb/rbae033. eCollection 2024.
8
Bioengineered Organoids Offer New Possibilities for Liver Cancer Studies: A Review of Key Milestones and Challenges.生物工程类器官为肝癌研究提供新可能:关键里程碑与挑战综述
Bioengineering (Basel). 2024 Apr 1;11(4):346. doi: 10.3390/bioengineering11040346.
9
Application of 3D Bioprinting in Liver Diseases.3D生物打印在肝脏疾病中的应用。
Micromachines (Basel). 2023 Aug 21;14(8):1648. doi: 10.3390/mi14081648.
Front Cell Dev Biol. 2022 Nov 28;10:1047524. doi: 10.3389/fcell.2022.1047524. eCollection 2022.
4
Vascularization Strategies in 3D Cell Culture Models: From Scaffold-Free Models to 3D Bioprinting.3D 细胞培养模型中的血管生成策略:从无支架模型到 3D 生物打印。
Int J Mol Sci. 2022 Nov 23;23(23):14582. doi: 10.3390/ijms232314582.
5
Editorial: Development of toxicology methods using organoid systems and toxicogenomic approaches.社论:利用类器官系统和毒理基因组学方法开发毒理学方法
Front Genet. 2022 Oct 3;13:1030580. doi: 10.3389/fgene.2022.1030580. eCollection 2022.
6
Dynamic changes of hepatic microenvironment related to graft function in donation after cardiac death liver transplantation.心脏死亡供肝移植中与移植物功能相关的肝微环境的动态变化。
Eur J Radiol. 2022 Sep;154:110424. doi: 10.1016/j.ejrad.2022.110424. Epub 2022 Jun 25.
7
Exploring the TEMPO-Oxidized Nanofibrillar Cellulose and Short Ionic-Complementary Peptide Composite Hydrogel as Biofunctional Cellular Scaffolds.探索 TEMPO 氧化纳米原纤纤维素和短离子互补肽复合水凝胶作为生物功能细胞支架。
Biomacromolecules. 2022 Jun 13;23(6):2496-2511. doi: 10.1021/acs.biomac.2c00234. Epub 2022 May 6.
8
Hepatocyte Differentiation from iPSCs or MSCs in Decellularized Liver Scaffold: Cell-ECM Adhesion, Spatial Distribution, and Hepatocyte Maturation Profile.去细胞化肝支架中 iPSCs 或 MSC 来源的肝细胞分化:细胞-细胞外基质黏附、空间分布和肝细胞成熟特征。
Organogenesis. 2022 Dec 31;18(1):2061263. doi: 10.1080/15476278.2022.2061263.
9
Review on Multicomponent Hydrogel Bioinks Based on Natural Biomaterials for Bioprinting 3D Liver Tissues.基于天然生物材料的多组分水凝胶生物墨水用于3D肝脏组织生物打印的综述
Front Bioeng Biotechnol. 2022 Feb 14;10:764682. doi: 10.3389/fbioe.2022.764682. eCollection 2022.
10
Mimicking Native Liver Lobule Microarchitecture In Vitro with Parenchymal and Non-parenchymal Cells Using 3D Bioprinting for Drug Toxicity and Drug Screening Applications.使用 3D 生物打印技术,通过实质细胞和非实质细胞在体外模拟天然肝小叶微结构,用于药物毒性和药物筛选应用。
ACS Appl Mater Interfaces. 2022 Mar 2;14(8):10167-10186. doi: 10.1021/acsami.2c00312. Epub 2022 Feb 16.